|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LXRX | BARKER SAM L | Director | May 13 '25 | Option Exercise | 0.00 | 36,810 | 0 | 124,459 | May 13 05:50 PM |
| LXRX | BARKER SAM L | Director | Apr 28 '24 | Option Exercise | 0.00 | 8,032 | 0 | 87,649 | Apr 29 04:17 PM |
| LXRX | BARKER SAM L | Director | May 21 '23 | Option Exercise | 0.00 | 9,302 | 0 | 79,617 | May 22 04:02 PM |
| LXRX | BARKER SAM L | Director | Apr 30 '22 | Option Exercise | 0.00 | 4,024 | 0 | 70,315 | May 02 04:12 PM |
| BGMS | BARKER SAM L | Director | Nov 30 '21 | Sale | 3.57 | 12 | 43 | 3,374 | Dec 02 04:07 PM |
| BGMS | BARKER SAM L | Director | Aug 24 '21 | Buy | 5.00 | 1,000 | 5,000 | 3,386 | Aug 25 04:16 PM |
| LXRX | BARKER SAM L | Director | Apr 24 '21 | Option Exercise | 0.00 | 10,638 | 0 | 66,291 | Apr 27 04:46 PM |
| LXRX | BARKER SAM L | Director | Apr 26 '20 | Option Exercise | 0.00 | 3,466 | 0 | 55,653 | Apr 27 04:44 PM |
| LXRX | BARKER SAM L | Director | Aug 02 '19 | Buy | 1.18 | 24,000 | 28,200 | 52,187 | Aug 02 04:12 PM |
| LXRX | BARKER SAM L | Director | Sep 15 '17 | Buy | 12.50 | 1,000 | 12,500 | 25,623 | Sep 18 06:36 AM |
| BGMS | BARKER SAM L | Director | Nov 20 '14 | Buy | 3.00 | 3,100 | 9,300 | 3,100 | Nov 20 04:24 PM |
| LXRX | BARKER SAM L | Director | Dec 22 '11 | Option Exercise | 1.13 | 34,000 | 38,420 | 100,000 | Dec 27 04:12 PM |
| LXRX | BARKER SAM L | Director | Oct 22 '09 | Buy | 1.56 | 19,000 | 29,672 | 31,000 | Oct 26 04:15 PM |
| LXRX | BARKER SAM L | Director | Apr 18 '08 | Buy | 1.96 | 40,000 | 78,570 | 47,000 | Apr 22 04:34 PM |
| AGIX | BARKER SAM L | Director | Jan 25 '08 | Buy | 0.39 | 5,000 | 1,950 | 6,000 | Feb 01 11:00 AM |
| AGIX | BARKER SAM L | Director | Jan 25 '08 | Buy | 0.39 | 20,000 | 7,800 | 20,000 | Feb 01 11:00 AM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite